Previous studies have demonstrated that SKP2 promotes Akt K63-mediated ubiquitination, enhancing the interaction between Akt and HK2, leading to increased cisplatin resistance in NPC [29]. This evidence concerns the gene SKP2 and nasopharyngeal carcinoma.